InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Prentiss Christopher B, Chief Financial Officer. Officer active across 3 companies, notably Adamas Pharmaceuticals Inc. In total, 9 reports have been published. History available since 24 November 2021. The latest transaction was filed on 15 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Prentiss Christopher B is Directeur Financier. He has 9 filings in total, and in the sampled recent filings, the activity runs from 2021-11-24 to 2026-07-17, with a total buy amount of EUR 0 and a total sell amount of EUR 0. The modal transaction nature is Attribution, and the companies mentioned are Mannkind CORP, MANNKIND CORP, and Adamas Pharmaceuticals Inc.